|
|
||||||||
Clinical Chemistry, Vol 40, 18-23, Copyright © 1994 by American Association for Clinical Chemistry
HA Schwertner, WG Jackson and G Tolan
USAF Medical Center/RDL, Lackland AFB, TX 78236-5319.
We examined serum bilirubin and various liver-function enzymes as possible risk factors for angiographically documented coronary artery disease (CAD). The studies involved a "training" set of 619 men for whom complete data on all risk factors considered were available, and a "test" set of 258 men for whom some risk factor data were not available. In both study groups, the liver enzymes were not related to CAD; however, In[total bilirubin] was inversely and statistically significantly related to the presence of CAD, both univariately and multivariately after adjustment for the established risk factors of age, total cholesterol, high-density lipoprotein cholesterol, smoking history, and systolic blood pressure. A 50% decrease in total bilirubin was associated with a 47% increase in the odds of being in a more severe CAD category. Our data suggest that serum bilirubin is an inverse and independent risk factor for CAD, with an association equivalent in degree to that of systolic blood pressure.
The following articles in journals at HighWire Press have cited this article:
![]() |
H. Kimm, J. E. Yun, J. Jo, and S. H. Jee Low Serum Bilirubin Level as an Independent Predictor of Stroke Incidence: A Prospective Study in Korean Men and Women Stroke, November 1, 2009; 40(11): 3422 - 3427. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Johnson, M. Kavousi, A. V. Smith, M.-H. Chen, A. Dehghan, T. Aspelund, J.-P. Lin, C. M. van Duijn, T. B. Harris, L. A. Cupples, et al. Genome-wide association meta-analysis for total serum bilirubin levels Hum. Mol. Genet., July 15, 2009; 18(14): 2700 - 2710. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Idriss, A. D. Blann, and G. Y.H. Lip Hemoxygenase-1 in Cardiovascular Disease J. Am. Coll. Cardiol., September 16, 2008; 52(12): 971 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Chen, L.-Y. Chau, J.-W. Chen, and S.-J. Lin Serum Bilirubin and Ferritin Levels Link Heme Oxygenase-1 Gene Promoter Polymorphism and Susceptibility to Coronary Artery Disease in Diabetic Patients Diabetes Care, August 1, 2008; 31(8): 1615 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rantner, B. Kollerits, M. Anderwald-Stadler, P. Klein-Weigel, I. Gruber, A. Gehringer, M. Haak, M. Schnapka-Kopf, G. Fraedrich, and F. Kronenberg Association between the UGT1A1 TA-Repeat Polymorphism and Bilirubin Concentration in Patients with Intermittent Claudication: Results from the CAVASIC Study Clin. Chem., May 1, 2008; 54(5): 851 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Perlstein, R. L. Pande, J. A. Beckman, and M. A. Creager Serum Total Bilirubin Level and Prevalent Lower-Extremity Peripheral Arterial Disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004 Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 166 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Ryter, D. Morse, and A. M. K. Choi Carbon Monoxide and Bilirubin: Potential Therapies for Pulmonary/Vascular Injury and Disease Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 175 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Stocker and M. A. Perrella Heme Oxygenase-1: A Novel Drug Target for Atherosclerotic Diseases? Circulation, November 14, 2006; 114(20): 2178 - 2189. [Full Text] [PDF] |
||||
![]() |
J.-P. Lin, C. J. O'Donnell, J. P. Schwaiger, L. A. Cupples, A. Lingenhel, S. C. Hunt, S. Yang, and F. Kronenberg Association Between the UGT1A1*28 Allele, Bilirubin Levels, and Coronary Heart Disease in the Framingham Heart Study Circulation, October 3, 2006; 114(14): 1476 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Ryter, J. Alam, and A. M. K. Choi Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications Physiol Rev, April 1, 2006; 86(2): 583 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Goodman, P. N. Chander, R. Rezzani, M. L. Schwartzman, R. F. Regan, L. Rodella, S. Turkseven, E. A. Lianos, P. A. Dennery, and N. G. Abraham Heme Oxygenase-2 Deficiency Contributes to Diabetes-Mediated Increase in Superoxide Anion and Renal Dysfunction J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1073 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Kirkby and C. A. Adin Products of heme oxygenase and their potential therapeutic applications Am J Physiol Renal Physiol, March 1, 2006; 290(3): F563 - F571. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gullu, D. Erdogan, D. Tok, S. Topcu, M. Caliskan, T. Ulus, and H. Muderrisoglu High Serum Bilirubin Concentrations Preserve Coronary Flow Reserve and Coronary Microvascular Functions Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2289 - 2294. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Morita Heme Oxygenase and Atherosclerosis Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1786 - 1795. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Hopkins, L. L. Wu, S. C. Hunt, and E. A. Brinton Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1003 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Keshavan, T. L. Deem, S. J. Schwemberger, G. F. Babcock, J. M. Cook-Mills, and S. D. Zucker Unconjugated Bilirubin Inhibits VCAM-1-Mediated Transendothelial Leukocyte Migration J. Immunol., March 15, 2005; 174(6): 3709 - 3718. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Abraham, R. Rezzani, L. Rodella, A. Kruger, D. Taller, G. Li Volti, A. I. Goodman, and A. Kappas Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2468 - H2477. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Sedlak and S. H. Snyder Bilirubin Benefits: Cellular Protection by a Biliverdin Reductase Antioxidant Cycle Pediatrics, June 1, 2004; 113(6): 1776 - 1782. [Full Text] [PDF] |
||||
![]() |
H. A. Schwertner Bilirubin Concentration, UGT1A1*28 Polymorphism, and Coronary Artery Disease Clin. Chem., July 1, 2003; 49(7): 1039 - 1040. [Full Text] [PDF] |
||||
![]() |
G. Endler, A. Hamwi, R. Sunder-Plassmann, M. Exner, T. Vukovich, C. Mannhalter, J. Wojta, K. Huber, and O. Wagner Is Low Serum Bilirubin an Independent Risk Factor for Coronary Artery Disease in Men but Not in Women? Clin. Chem., July 1, 2003; 49(7): 1201 - 1204. [Full Text] [PDF] |
||||
![]() |
L. Novotny and L. Vitek Inverse Relationship Between Serum Bilirubin and Atherosclerosis in Men: A Meta-Analysis of Published Studies Experimental Biology and Medicine, May 1, 2003; 228(5): 568 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Baranano, M. Rao, C. D. Ferris, and S. H. Snyder From the Cover: Biliverdin reductase: A major physiologic cytoprotectant PNAS, December 10, 2002; 99(25): 16093 - 16098. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kaneda, M. Ohno, J. Taguchi, M. Togo, H. Hashimoto, K. Ogasawara, T. Aizawa, N. Ishizaka, and R. Nagai Heme Oxygenase-1 Gene Promoter Polymorphism Is Associated With Coronary Artery Disease in Japanese Patients With Coronary Risk Factors Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1680 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Durante Carbon monoxide and bile pigments: surprising mediators of vascular function Vascular Medicine, August 1, 2002; 7(3): 195 - 202. [Abstract] [PDF] |
||||
![]() |
P. G. V. Hoydonck, E. H. Temme, and E. G Schouten Serum bilirubin concentration in a Belgian population: the association with smoking status and type of cigarettes Int. J. Epidemiol., December 1, 2001; 30(6): 1465 - 1472. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ishizaka, Y. Ishizaka, E. Takahashi, M. Yamakado, and H. Hashimoto High Serum Bilirubin Level Is Inversely Associated With the Presence of Carotid Plaque Stroke, February 1, 2001; 32 (2): 580 - 583. [Full Text] [PDF] |
||||
![]() |
M. Mayer Association of Serum Bilirubin Concentration with Risk of Coronary Artery Disease Clin. Chem., November 1, 2000; 46(11): 1723 - 1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Cunningham, A. Dunne, P. Sabido, D. Lightner, and T. J. Mantle Studies on the Specificity of the Tetrapyrrole Substrate for Human Biliverdin-IXalpha Reductase and Biliverdin-IXbeta Reductase. STRUCTURE-ACTIVITY RELATIONSHIPS DEFINE MODELS FOR BOTH ACTIVE SITES J. Biol. Chem., June 16, 2000; 275(25): 19009 - 19017. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Durante, K. J. Peyton, and A. I. Schafer Platelet-Derived Growth Factor Stimulates Heme Oxygenase-1 Gene Expression and Carbon Monoxide Production in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2666 - 2672. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dore, M. Takahashi, C. D. Ferris, L. D. Hester, D. Guastella, and S. H. Snyder Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury PNAS, March 2, 1999; 96(5): 2445 - 2450. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C.M. Siow, H. Sato, and G. E. Mann Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res, February 1, 1999; 41(2): 385 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Beutler, T. Gelbart, and A. Demina Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism? PNAS, July 7, 1998; 95(14): 8170 - 8174. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Tracy Inflammation in Cardiovascular Disease : Cart, Horse, or Both? Circulation, May 26, 1998; 97(20): 2000 - 2002. [Full Text] [PDF] |
||||
![]() |
S. C. Hunt, L. L. Wu, P. N. Hopkins, and R. R. Williams Evidence for a Major Gene Elevating Serum Bilirubin Concentration in Utah Pedigrees Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 912 - 917. [Abstract] [Full Text] |
||||
![]() |
P. N. Hopkins, L. L. Wu, S. C. Hunt, B. C. James, G. M. Vincent, and R. R. Williams Higher Serum Bilirubin Is Associated With Decreased Risk for Early Familial Coronary Artery Disease Arterioscler Thromb Vasc Biol, February 1, 1996; 16(2): 250 - 255. [Abstract] [Full Text] |
||||
![]() |
V. W. Bowry, D. Mohr, J. Cleary, and R. Stocker Prevention of Tocopherol-mediated Peroxidation in Ubiquinol-10-free Human Low Density Lipoprotein J. Biol. Chem., March 17, 1995; 270(11): 5756 - 5763. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |